New injection tested to calm dangerous pancreatitis inflammation
NCT ID NCT03401190
Summary
This study tested an investigational injection called CM4620-IE in adults hospitalized with acute pancreatitis and a dangerous whole-body inflammatory response (SIRS). The main goal was to check the safety of the drug and see how well it worked when added to standard hospital care. Researchers looked at whether the treatment helped reduce inflammation, improved patients' ability to eat, and shortened hospital stays.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PANCREATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ben Taub (Baylor College of Medicine)
Houston, Texas, 77030, United States
-
Detroit Receiving Hospital (Wayne State)
Detroit, Michigan, 48201, United States
-
Hennepin County Medical Center
Minneapolis, Minnesota, 55415, United States
-
Henry Ford Hospital
Detroit, Michigan, 48202, United States
-
MetroHealth (Case Western)
Cleveland, Ohio, 44109, United States
-
Regions Hospital
Saint Paul, Minnesota, 55101, United States
-
Riverside Methodist
Columbus, Ohio, 43214, United States
-
Sinai-Grace Hospital (Wayne State)
Detroit, Michigan, 48235, United States
-
Washington University
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.